Literature DB >> 21836503

Sacrospinous ligament fixation for pelvic organ prolapse in the era of vaginal mesh kits.

Tajnoos Yazdany1, Keri Wong, Narender N Bhatia.   

Abstract

PURPOSE OF REVIEW: To examine the sacrospinous ligament as a point of attachment for pelvic organ prolapse procedures, including vaginal mesh kits. RECENT
FINDINGS: Pelvic surgeons are increasingly employing the sacrospinous ligament as a point of attachment for biologic grafts and synthetic mesh kits during uterovaginal prolapse repairs. These techniques may have introduced a novel set of complications (mesh extrusion, erosion) in addition to those already known to occur in traditional sacrospinous ligament fixations. Except for limited short-term results, little data are available in the literature regarding surgical outcomes and complications for mesh and graft augmented repairs attached to the sacrospinous ligament.
SUMMARY: The sacrospinous ligament fixation is a well tolerated and effective procedure for suspension of the vaginal apex. Mesh augmentation using the sacrospinous ligament may improve objective prolapse recurrence, but complications still occur, including those specific to mesh placement. (C) 2011 Lippincott Williams & Wilkins, Inc.

Mesh:

Year:  2011        PMID: 21836503     DOI: 10.1097/GCO.0b013e32834ac743

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  2 in total

1.  Transforming growth factor β 1 gene expression during vaginal vs cutaneous surgical woundexpression during vaginal vs cutaneous surgical wound healing in the rabbit.

Authors:  Yoram Abramov; Emmet Hirsch; Vladimir Ilievski; Roger P Goldberg; Sylvia M Botros; Peter K Sand
Journal:  Int Urogynecol J       Date:  2012-08-08       Impact factor: 2.894

2.  Manometric comparison of anorectal function after posterior vaginal compartment repair with and without mesh.

Authors:  Shuo Liang; Lan Zhu; Lei Zhang; Zhi-Jing Sun; Xu Tao; Jing-He Lang Lang
Journal:  Chin Med J (Engl)       Date:  2015-02-20       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.